Hong Ma
88 Jiefang Road
Hangzhou, 310009, China
Hangzhou, 310009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Diverging trajectories of cardiorenal protection: From early benefit to late attenuation with multifactorial target achievement across cardiovascular kidney-metabolic syndrome stages.
Journal: International journal of cardiology
Published: March 19, 2026
TMC6 Is a Novel Therapeutic Target for Pathogenic Cardiac Hypertrophy.
Journal: Circulation research
Published: February 25, 2026
RBP1 attenuates pathological cardiac hypertrophy via Wnt3a/β-catenin signaling.
Journal: Journal of molecular and cellular cardiology
Published: February 21, 2026
TREM2+ macrophages confers post-infarction cardioprotection by restraining ROS via NLRP3 inflammasome.
Journal: Biochemical pharmacology
Published: February 06, 2026
Grhl3 Downregulation Facilitates ECM Adaptation for Fibroblast to iCM Commitment.
Journal: Circulation research
Published: January 15, 2026
Extracellular Vesicles in Cardiovascular Diseases: Signaling, Biomarker, and Therapy.
Journal: Journal of cardiovascular translational research
Published: June 05, 2025
Integrin αV emerges as a potential therapeutic target with cautionary implications in thoracic aortic aneurysm and dissection.
Journal: The Journal of thoracic and cardiovascular surgery
Published: May 07, 2025
GSTM1 suppresses cardiac fibrosis post-myocardial infarction through inhibiting lipid peroxidation and ferroptosis.
Journal: Military Medical Research
Published: October 26, 2024
Last Updated: 09/26/2026